1. Home
  2. KOS vs IVA Comparison

KOS vs IVA Comparison

Compare KOS & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kosmos Energy Ltd. (DE)

KOS

Kosmos Energy Ltd. (DE)

HOLD

Current Price

$1.07

Market Cap

798.7M

Sector

Energy

ML Signal

HOLD

Logo Inventiva S.A. American Depository Shares

IVA

Inventiva S.A. American Depository Shares

HOLD

Current Price

$4.18

Market Cap

769.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KOS
IVA
Founded
2003
2011
Country
United States
France
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
798.7M
769.0M
IPO Year
2011
2020

Fundamental Metrics

Financial Performance
Metric
KOS
IVA
Price
$1.07
$4.18
Analyst Decision
Buy
Strong Buy
Analyst Count
4
7
Target Price
$3.20
$17.14
AVG Volume (30 Days)
12.3M
293.4K
Earning Date
11-03-2025
09-29-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,392,234,000.00
$19,929,536.00
Revenue This Year
N/A
N/A
Revenue Next Year
$18.47
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.03
$2.11
52 Week High
$4.01
$7.98

Technical Indicators

Market Signals
Indicator
KOS
IVA
Relative Strength Index (RSI) 28.00 46.30
Support Level $1.03 $3.98
Resistance Level $1.17 $4.47
Average True Range (ATR) 0.08 0.23
MACD -0.01 0.05
Stochastic Oscillator 8.33 47.83

Price Performance

Historical Comparison
KOS
IVA

About KOS Kosmos Energy Ltd. (DE)

Kosmos Energy Ltd is a deepwater exploration and production company focused on meeting the world's growing demand for energy. It has diversified oil and gas production from assets offshore Ghana, Equatorial Guinea, Mauritania, Senegal and the Gulf of America. The Company had operations in four geographic reporting segments: Ghana, Equatorial Guinea, Mauritania/Senegal and the Gulf of America. The majority of revenue is derived from the Ghana segment.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Share on Social Networks: